synthes
cellulos
membran
tenaminoacid
peptid
includ
sequenc
predict
sever
acut
respiratori
syndrom
sar
corona
viru
probe
membran
four
pair
acut
convalesc
sera
recov
sar
case
correl
posit
react
peptid
vitro
sarscov
neutral
activ
sampl
found
convalesc
sera
high
neutral
activ
recogn
exclus
limit
number
peptid
membran
suggest
antibodi
epitop
repres
peptid
could
respons
much
sarscov
neutral
activ
find
implic
monitor
humor
respons
sarscov
well
develop
success
sar
vaccin
newli
identifi
viru
name
sarscov
establish
etiolog
agent
sever
acut
respiratori
syndrom
sar
total
probabl
case
highli
infecti
diseas
report
august
includ
death
http
wwwwhointcsrsarsen
viral
genom
sequenc
marra
et
al
rota
et
al
consist
nucleotid
contain
identifi
open
read
frame
peptid
incorpor
sequenc
predict
open
read
frame
sarscov
genom
prepar
derivat
cellulos
membran
use
robot
peptid
synthes
autospot
asp
intavi
bioanalyt
instrument
lagenfeld
germani
peptid
amino
acid
long
overlap
eight
residu
peptid
membran
therefor
shift
one
previou
two
amino
acid
toward
ctermin
end
arrang
peptid
set
four
membran
cover
open
read
frame
orf
illustr
fig
membran
probe
pair
acut
convalesc
sera
four
case
recov
sar
infect
control
serum
one
case
fail
surviv
one
healthi
nonexpos
volunt
util
sampl
dilut
buffer
appli
membran
h
jc
membran
develop
horseradish
peroxidaseconjug
goat
antibodi
human
igg
igm
iga
posit
spot
identifi
follow
treatment
ecl
chemiluminesc
reagent
sera
test
presenc
antibodi
sarscov
standard
viru
neutral
test
serial
dilut
serum
incub
plaqueform
unit
sarscov
isol
marra
et
al
h
ad
monolay
vero
cell
cultur
examin
h
presenc
characterist
cytopath
effect
dilut
one
cytopath
effect
first
note
record
antiviru
titer
sera
show
evid
antiviru
activ
retest
follow
heat
treatment
jc
min
process
confirm
presenc
neutral
antibodi
elimin
possibl
nonspecif
heatsensit
factor
contribut
neutral
activ
result
neutral
assay
variou
sera
shown
tabl
along
age
sex
respect
patient
acut
sera
collect
present
convalesc
sera
collect
month
later
case
least
week
later
case
acut
serum
case
neutral
antibodi
titer
indic
begin
immun
respons
acut
sera
well
acut
serum
deceas
case
taken
day
ill
onset
healthi
control
detect
neutral
activ
data
indic
four
recov
case
develop
antibodi
viral
neutral
potenc
time
acut
convalesc
serum
sampl
therefor
peptid
strongli
recogn
membran
probe
convalesc
sera
acut
control
sera
immunodomin
may
includ
sarscov
epitop
vulner
neutral
antibodi
analysi
limit
linear
epitop
sinc
peptid
membran
replic
conform
epitop
develop
posttransl
modif
glycosyl
three
exampl
membran
react
acut
convalesc
sera
develop
antiiga
antibodi
shown
fig
fig
compar
second
panel
membran
probe
serum
unexpos
control
deceas
case
convalesc
serum
case
acut
convalesc
serum
case
panel
total
peptid
encod
orf
open
read
frame
see
fig
spot
strongli
immunostain
except
singl
triad
two
convalesc
sera
peptid
triad
follow
sequenc
sddyiklngp
dyiklngplt
iklngpvg
sequenc
iklngp
common
three
fig
compar
third
panel
membran
probe
acut
convalesc
serum
case
deceas
case
panel
peptid
encod
sprotein
open
read
frame
one
triad
spot
immunoposit
convalesc
acut
serum
triad
follow
sequenc
fqpfqqfgrd
pfqqfgrdv
qqfgrdvsdf
common
sequenc
qqfgrd
fig
compar
fourth
panel
membran
probe
acut
convalesc
serum
case
convalesc
serum
case
bottom
half
membran
peptid
encod
complet
nucleocapsid
n
protein
open
read
frame
one
triad
immunoposit
two
convalesc
sera
posit
correspond
acut
serum
case
triad
follow
sequenc
qlpqgttlpk
pqgttlpkgf
gttlpkgfya
common
sequenc
gttlpk
shown
tabl
overlap
membran
peptid
recogn
exclus
much
strongli
multipl
pair
convalesc
compar
respect
acut
sera
none
peptid
recogn
serum
deceas
case
healthi
control
two
overlap
sequenc
orf
one
orf
six
nprotein
eleven
sprotein
two
mprotein
one
e
protein
one
orf
remain
open
read
frame
reactiv
one
serum
sampl
tabl
peptid
list
sequenc
amino
acid
identifi
combin
three
adjac
spot
membran
wherea
list
identifi
combin
two
adjac
spot
common
sequenc
therefor
includ
residu
peptid
peptid
note
right
show
key
orf
peptid
total
bracket
membran
spot
dye
instead
amino
acid
actual
membran
spot
peptid
adjac
spot
shift
two
amino
acid
character
immun
respons
singl
case
epitop
promis
provid
import
insight
role
resolut
infect
howev
epitop
recogn
multipl
convalesc
sera
may
import
target
neutral
antibodi
b
exampl
membran
panel
probe
variou
serum
sampl
develop
peroxidaselabel
goat
antihuman
iga
b
probe
control
serum
acut
well
convalesc
serum
case
convalesc
serum
case
serum
deceas
case
notic
triad
spot
recogn
serum
two
convalesc
case
peptid
sequenc
orf
sddyiklngp
dyiklngplt
iklngpltvg
c
probe
acut
chronic
serum
case
serum
deceas
case
panel
peptid
sprotein
notic
triad
spot
recogn
convalesc
serum
peptid
sequenc
sprotein
fqpfqqfgrd
pfqqfgrdv
qqfgrdvsdf
probe
acut
convalesc
serum
case
convalesc
serum
case
notic
triad
spot
recogn
two
convalesc
sera
peptid
sequenc
nprotein
qlpqgttlpk
pqgttlpkgf
gttlpkgfya
addit
peptid
shown
tabl
recogn
convalesc
serum
one
four
case
among
singl
case
exampl
peptid
orf
orf
orf
orf
orf
indic
viru
express
protein
antibodi
certain
epitop
produc
character
immun
respons
singl
case
epitop
promis
provid
import
insight
role
resolut
infect
howev
epitop
recogn
multipl
convalesc
sera
may
import
develop
antibodi
protect
viru
knowledg
function
sarscov
protein
mostli
deriv
analog
wellcharacter
corona
virus
kb
total
genom
taken
orf
orf
presum
encod
protein
proteas
polymeras
associ
viru
replic
marra
et
al
ruan
et
al
genom
suffici
uniqu
propos
belong
separ
group
design
group
iv
marra
et
al
ruan
et
al
view
consensu
note
sarscov
close
relat
group
coronavirus
snijder
et
al
nevertheless
structur
protein
n
e
clearli
identifi
viru
grown
infect
cell
marra
et
al
ruan
et
al
spike
sprotein
protrud
outer
surfac
strong
candid
facilit
viral
entri
host
cell
li
et
al
report
sarscov
sprotein
effici
bind
angiotensin
convert
enzym
sarscov
permiss
vero
cell
suggest
bind
key
step
sarscov
infect
interact
sprotein
corona
viru
specif
mammalian
receptor
determin
speci
sensit
exampl
sprotein
ectodomain
mous
corona
hepat
viru
replac
felin
infecti
periton
viru
viral
particl
longer
infect
mous
cell
becam
infect
felin
cell
kuo
et
al
sarscov
report
infect
domest
cat
ferret
martina
et
al
relationship
may
relev
broader
speci
suscept
exampl
interact
sprotein
mammalian
receptor
involv
aminopeptidas
n
main
mammalian
receptor
sprotein
mani
coronavirus
substitut
human
cell
human
nglycosyl
site
porcin
nglycosyl
site
result
failur
bind
human
corona
wentworth
holm
antibodi
direct
epitop
sprotein
identifi
tabl
therefor
potenti
candid
neutral
activ
antibodi
mprotein
eprotein
epitop
could
also
import
although
smaller
believ
less
expos
protein
encod
orf
may
display
viral
surfac
immun
respons
may
contribut
resolut
diseas
antibodi
orf
orf
nprotein
probabl
unlik
contribut
vitro
neutral
result
nprotein
intern
probabl
inaccess
brief
exposur
time
neutral
test
product
orf
orf
believ
structur
protein
nevertheless
may
import
vivo
protect
given
complex
antibodi
produc
convalesc
serum
would
difficult
predict
rel
contribut
overal
neutral
activ
might
particularli
antibodi
conform
carbohydratedepend
epitop
might
present
nevertheless
high
titer
consist
repres
variou
convalesc
sera
might
suffici
confer
immun
numer
strategi
suggest
produc
sar
vaccin
degroot
one
possibl
use
combin
peptid
list
tabl
sequenc
amino
acid
repres
three
adjac
peptid
common
sequenc
residu
sequenc
amino
acid
repres
two
adjac
peptid
common
sequenc
residu
amino
acid
posit
aa
sarscov
open
read
frame
taken
blast
ncbi
http
wwwncbinlmnihgovblastblastcgi
polyval
antigen
peptidebas
vaccin
heretofor
limit
success
attribut
lack
knowledg
peptid
use
uncertainti
reduc
analyz
antibodi
pattern
sera
case
success
resolv
infect
peptid
make
antigen
screen
advanc
homolog
mammalian
protein
reduc
possibl
selfattack
also
easili
modifi
cope
viral
mutat
could
escap
tradit
vaccin
signific
mutat
alreadi
identifi
sarscov
ruan
et
al
martina
et
al
indic
necess
develop
adapt
vaccin
polypeptid
vaccin
safe
highli
stabl
easi
administ
antibodi
clone
particularli
sensit
peptid
could
use
therapeut
agent
type
analysi
describ
may
gener
util
design
peptid
vaccin
therapeut
antibodi
infecti
agent
hiv
cellulosebound
overlap
peptid
mer
deriv
protein
encod
orf
sar
genom
synthes
use
autospot
robot
provid
intavi
bioanalyt
instrument
softwar
use
design
array
digen
jerini
biotool
gmbh
berlin
germani
membran
derivat
polyethylen
peg
linker
free
amino
termin
well
fmoc
amino
acid
obtain
intavi
bioanalyt
instrument
fmoc
amino
acid
dissolv
dimethylformamid
dmf
sigma
oakvil
ont
canada
activ
hobt
sigma
n
n
v
disopropylcarbodiimid
dipc
sigma
least
min
deliv
membran
aliquot
per
spot
robot
synthes
fifteen
minut
complet
cycl
membran
remov
apparatu
treat
acet
anhydrid
dmf
acetyl
free
remain
amino
group
wash
treat
piperidin
dmf
remov
fmoc
protect
group
follow
wash
dmf
methanol
final
air
dri
membran
precis
reposit
robot
apparatu
initi
next
coupl
cycl
final
cycl
side
chain
protect
group
remov
treatment
solut
follow
composit
ml
trifluoracet
acid
ml
dichloromethan
dcm
al
triisopropyl
silan
sigma
al
water
membran
wash
twice
dcm
twice
dmf
twice
methanol
air
dri
membran
store
seal
bag
jc
use
membran
rehydr
treat
first
methanol
methanol
follow
wash
three
time
mm
trisbuff
tween
tbst
block
skim
milk
tbst
overnight
jc
wash
three
time
tbst
membran
incub
jc
h
dilut
serum
sampl
patient
control
wash
membran
treat
dilut
agml
goat
antihuman
iga
igg
igm
antibodi
conjug
horseradish
peroxidas
sigma
wash
tbst
membran
develop
ecl
chemiluminesc
kit
provid
amersham
pharmacia
biotech
buckinghamshir
england
four
millilit
two
ecl
western
blot
detect
reagent
mix
appli
membran
membran
scan
use
biorad
fluoresc
imag
hercul
ca
save
later
analysi
membran
regener
incub
sd
overnight
follow
min
acet
acid
step
membran
wash
three
time
methanol
air
dri
store
jc
seal
bag
reus
initi
develop
sarscov
serum
neutral
test
comparison
made
microneutr
test
plaqu
reduct
assay
test
sever
sera
consist
produc
assay
result
plaqu
reduct
titer
greater
microneutr
test
follow
valid
microneutr
test
system
adopt
greater
conveni
despit
greater
sensit
plaqu
reduct
assay
typic
result
assay
illustr
fig
